The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis

Open Access

Peer-reviewed

Research Article

Ruoshuang Zhang,

Affiliation Department of Ophthalmology, The first affiliated hospital of China Medical University, Shenyang City, liaoning Province, China
⨯
Zheli Liu ,

* E-mail: zheli_liu@163.com

Affiliation Department of Ophthalmology, The first affiliated hospital of China Medical University, Shenyang City, liaoning Province, China
⨯
Han Zhang,

Affiliation Department of Ophthalmology, The first affiliated hospital of China Medical University, Shenyang City, liaoning Province, China
⨯
Yi Zhang,

Affiliation Department of Ophthalmology, The first affiliated hospital of China Medical University, Shenyang City, liaoning Province, China
⨯
Dong Lin

Affiliation Department of Ophthalmology, The first affiliated hospital of China Medical University, Shenyang City, liaoning Province, China
⨯

Reader Comments (0)

Fibrosis
Is the Subject Area "Fibrosis" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Macrophages
Is the Subject Area "Macrophages" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Eyes
Is the Subject Area "Eyes" applicable to this article?

Thanks for your feedback.
Macular degeneration
Is the Subject Area "Macular degeneration" applicable to this article?

Thanks for your feedback.
COX-2 inhibitors
Is the Subject Area "COX-2 inhibitors" applicable to this article?

Thanks for your feedback.